Xaira Therapeutics, which aims to use AI models to find new drugs to treat diseases, emerged from stealth with $1B in commitments from Sequoia and others
read it only @endpts: https://endpts.com/... LinkedIn: Xaira Therapeutics : Incubated by ARCH Venture Partners and Foresite Labs, Xaira Therapeutics is on a mission to drive advances in artificial intelligence to learn the language of life and transform how we treat disease. … Philip Leung : Excited to finally share publicly what we've been working on since September (but really for over a year)! … Vik Bajaj : This is the moment to re-engineer the entire drug discovery and development process. Driven by growing data sets and new methods … Scott Gottlieb : I'm delighted to share news of this new AI-focused drug discovery company, Xaira, built on foundational technology from David Baker and led by Marc Tessier-Lavigne. … Hetu K : We are at the dawn of a new era in Drug Discovery powered by AI. Excited to be working on this mission with an amazing team at Xaira Therapeutics! …